title: [Presumed benign ovarian tumors during pregnancy].
abstract: The incidence of ovarian tumors diagnosed during pregnancy is between 0.3 and 5.4% (LE2). The most common ovarian tumors diagnosed during pregnancy are functional cysts diagnosed incidentally during the first trimester ultrasound (LE2) and spontaneous regression is often observed. Dermoid cysts and cystadenoma are the most frequent organic benign ovarian tumors diagnosed during pregnancy (LE2). The main complication of presumed benign ovarian tumor (PBOT) during pregnancy is adnexal torsion and is estimated at around 8% (LE2), especially at the end of the first trimester and during the second trimester (LE4). Tumor markers are not reliable during pregnancy to assess the risk of malignancy of ovarian tumor (LE2). Ultrasound remains the gold standard for characterizing an ovarian tumor during pregnancy (LE3), but with a lower specificity for the diagnosis of malignancy. Pelvic MRI is accurate in the diagnosis of ovarian tumors during pregnancy and brings additional information to ultrasound (LE4). Ultrasound-guided aspiration of ovarian tumors is not recommended during pregnancy (grade C). Expectation is recommended in cases of PBOT during pregnancy, which does not enlarge (grade C). Whatever the gestational age, surgery is recommended in patients with symptoms suggesting an adnexal torsion (grade C). Laparoscopy is possible during the first and second trimester of pregnancy for the management of symptomatic PBOT (LE3). The risk of miscarriage following surgery (laparoscopy and laparotomy) for ovarian tumor during pregnancy is estimated at 2.8% (LE3). The route of delivery should not be modified by the ovarian tumour, except in case of praevia cyst requiring a cesarean section, a complication or suspicion of malignancy (grade C). Surgical treatment of PBOT may be performed during a cesarean section indicated for another reason. The risk of torsion is increased during the postpartum period (LE4).
authors.affiliation: Service de gynécologie-obstétrique, hôpital de la Croix-Rousse, 103, Grande-Rue-de-la-Croix-Rousse, 69004 Lyon, France; Université Claude-Bernard Lyon-1, 43, boulevard du 11-Novembre-1918, 69622 Villeurbanne cedex, France.
authors.forename: O
authors.initials: O
authors.lastname: Tariel
authors.forename: C
authors.initials: C
authors.lastname: Huissoud
authors.forename: R C
authors.initials: RC
authors.lastname: Rudigoz
authors.forename: G
authors.initials: G
authors.lastname: Dubernard
mesh_terms: D036861:Delivery, Obstetric / Q000706:statistics & numerical data; D018450:Disease Progression; D005260:Female; D006801:Humans; D010048:Ovarian Cysts / Q000000981:diagnostic imaging / Q000453:epidemiology; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology; D011230:Precancerous Conditions / Q000000981:diagnostic imaging / Q000453:epidemiology; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000000981:diagnostic imaging / Q000453:epidemiology; D013724:Teratoma / Q000000981:diagnostic imaging / Q000453:epidemiology; D016216:Ultrasonography, Prenatal
keywords: Adnexal mass; Grossesse; IRM; Laparoscopie; Laparoscopy; MR imaging; Masse annexielle; Pregnancy; Ultrasonography; Échographie